Lv54
1418 积分 2024-08-02 加入
A Phase I Study Comparing the Pharmacokinetics, Safety, and Immunogenicity of A140 Injection and Cetuximab (Erbitux®) in Healthy Chinese Male Subjects
22天前
已完结
Practical approach to blood compatibility assessments: General considerations and standards
1个月前
已关闭
Hyperacute rejection-engineered oncolytic virus for interventional clinical trial in refractory cancer patients
1个月前
已完结
Dietary fructose improves intestinal cell survival and nutrient absorption
2个月前
已完结
A Bayesian interval dose-finding design addressingOckham's razor: mTPI-2
3个月前
已完结
Industry experiences with immune-mediated findings in biotherapeutic nonclinical toxicology studies
4个月前
已完结
Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Stapokibart in Healthy Volunteers and Adult Subjects with Atopic Dermatitis
5个月前
已完结
Poziotinib treatment in patients with HER2-positive advanced breast cancer who have received prior anti-HER2 regimens
6个月前
已完结
Antibody drug conjugates in non-small cell lung cancer: An emerging therapeutic approach
6个月前
已完结
Safety, pharmacokinetics and pharmacodynamics of SHR-1703, an innovative long-acting anti-interleukin-5 monoclonal antibody, in healthy subjects: a randomized, double-blind, dose-escalation, placebo-controlled phase I study
7个月前
已完结
皖公网安备34019202002308
